← Leaderboards
Ruth A. Mulnard
University Of California Irvine
$1,191,667
Attributed
$1,191,667
Total exposure
33
Grants
29
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $160.2K · FY2005–14$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,191,667 · 33
By mechanism
P50$875,038 · 2
M01$316,629 · 31
Top collaborators
No co-investigators on record.
Most similar at University Of California Irvine
Same institution · by research overlap
- Larry E. Overman$11,686,672
- Xiaoning Bi$4,059,320
- Ira T Lott$14,129,643
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseGrantResearch PersonnelClinical TrialsResourcesFundingComputer Retrieval Of Information On Scientific Projects DatabaseSourceUnited States National Institutes Of HealthInstitutionPlacebosClinical ResearchHuman SubjectRandomizedDementiaAlzheimer'S DiseaseBaseEducational AspectsHuman Therapy EvaluationLongitudinal Human StudyBrainPreventInstitutes
Grant awards (56)
EDUCATION AND INFORMATION TRANSFER CORE$109,982
P50 · FY2014 · AG · contact PI
EDUCATION AND INFORMATION TRANSFER CORE$84,225
P50 · FY2013 · AG · contact PI
EDUCATION AND INFORMATION TRANSFER CORE$21,767
P50 · FY2013 · AG · contact PI
EDUCATION AND INFORMATION TRANSFER CORE$91,472
P50 · FY2012 · AG · contact PI
EDUCATION AND INFORMATION TRANSFER CORE$88,841
P50 · FY2011 · AG · contact PI
EDUCATION AND INFORMATION TRANSFER CORE$89,739
P50 · FY2010 · AG · contact PI
MULTI-CENTER TRIAL TO EVALUATE HOME-BASED ASSESSMENT METHODS FOR ALZHEIMER DISEA$518
M01 · FY2010 · RR · contact PI
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE$518
M01 · FY2010 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$95,585
P50 · FY2009 · AG · contact PI
MULTI-CENTER TRIAL TO EVALUATE HOME-BASED ASSESSMENT METHODS FOR ALZHEIMER DISEA$14,154
M01 · FY2009 · RR · contact PI
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE$9,626
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: ESTROGEN PREVENTION TRIAL$6,794
M01 · FY2009 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$92,796
P50 · FY2008 · AG · contact PI
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE$8,243
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: ESTROGEN PREVENTION TRIAL$4,579
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: EVALUATION OF THE SAFETY, TOLERABILITY AND IMPACT ON BIOMARKERS$3,205
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: HUPERZINE A TRIAL$2,290
M01 · FY2008 · RR · contact PI
PI PROTOCOL$916
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLE$457
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: HOMOCYSTEINE TRIAL$457
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: STATIN TRIAL$457
M01 · FY2008 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$92,298
P50 · FY2007 · AG · contact PI
PI PROTOCOL$9,690
M01 · FY2007 · RR · contact PI
HUPERZINE A TRIAL$6,590
M01 · FY2007 · RR · contact PI
HOMOCYSTEINE TRIAL$6,201
M01 · FY2007 · RR · contact PI
ESTROGEN PREVENTION TRIAL$5,427
M01 · FY2007 · RR · contact PI
STATIN TRIAL$3,101
M01 · FY2007 · RR · contact PI
VALPROATE TRIAL$2,326
M01 · FY2007 · RR · contact PI
EVALUATION OF THE SAFETY, TOLERABILITY AND IMPACT ON BIOMARKERS OF ANTI-OXIDANT$1,163
M01 · FY2007 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$54,967
P50 · FY2006 · AG · contact PI
HOMOCYSTEINE TRIAL$21,022
M01 · FY2006 · RR · contact PI
STATIN TRIAL$14,715
M01 · FY2006 · RR · contact PI
PI PROTOCOL$13,138
M01 · FY2006 · RR · contact PI
VALPROATE TRIAL$10,512
M01 · FY2006 · RR · contact PI
ESTROGEN PREVENTION TRIAL$6,832
M01 · FY2006 · RR · contact PI
PLATELET APP STUDY$2,628
M01 · FY2006 · RR · contact PI
HUPERZINE A TRIAL$525
M01 · FY2006 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$53,366
P50 · FY2005 · AG
HOMOCYSTEINE TRIAL$29,306
M01 · FY2005 · RR
STATIN TRIAL$23,201
M01 · FY2005 · RR
VALPROATE TRIAL$20,758
M01 · FY2005 · RR
PI PROTOCOL$17,094
M01 · FY2005 · RR
ESTROGEN PREVENTION TRIAL$8,548
M01 · FY2005 · RR
PLATELET APP STUDY$6,105
M01 · FY2005 · RR
HUPERZINE A TRIAL$1,222
M01 · FY2005 · RR
INFORMED CONSENT STUDY$610
M01 · FY2005 · RR
Homocysteine Trial$15,343
M01 · FY2004 · RR
PI Protocol$13,573
M01 · FY2004 · RR
Estrogen Prevention Trial$8,851
M01 · FY2004 · RR
Statin Trial$4,721
M01 · FY2004 · RR
NL Protocol$2,951
M01 · FY2004 · RR
Platelet APP Study$2,951
M01 · FY2004 · RR
MCI Trial$2,360
M01 · FY2004 · RR
Informed Consent Study$1,770
M01 · FY2004 · RR
Valproate Trial$1,181
M01 · FY2004 · RR
Core--Education and Information Transfer$0
P50 · FY2000 · AG